Precision for Medicine Executive and Leadership Team

June, 2026

Leadership Overview

Precision for Medicine has 5 executives leading key functions including finance, operations, and clinical solutions.

Driven by a commitment to innovation, Precision for Medicine supports life science companies by accelerating drug approvals, reducing development costs, and optimizing market entry strategies, thereby enhancing global health outcomes.

Leadership Roles at Precision for Medicine

  • Chief Financial Officer - Eugene Vodovoz
  • President and Chief Operating Officer, Precision Medicine Group - Charles Clark
  • President, Precision for Medicine - Sofia Baig
  • President, Clinical Solutions - Daisy DeWeese-Gatt
  • Senior VP (Asia Pacific) - James Cheong
  • Eugene Vodovoz - Chief Financial Officer

    Eugene Vodovoz, the Chief Financial Officer at Precision for Medicine, directs all financial operations and strategic fiscal planning. Vodovoz oversees budgeting, forecasting, and resource allocation, ensuring robust financial health across the organization. This leadership position involves managing investor relations and securing capital to fuel expansion initiatives. By optimizing financial workflows, Eugene Vodovoz directly supports the company's mission to accelerate life science advancements. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding the company's assets and reputation. This role is critical in translating strategic objectives into actionable financial targets, driving sustainable growth and profitability. Vodovoz's expertise ensures that financial strategies align with the company's overarching goal of speeding approval and reducing costs for life science partners.

    Charles Clark - President and Chief Operating Officer, Precision Medicine Group

    Charles Clark, the President and Chief Operating Officer, Precision Medicine Group at Precision for Medicine, orchestrates the company's operational framework and strategic execution. Clark directs day-to-day business activities, ensuring seamless integration of services that support life science companies. This executive role involves optimizing operational efficiency to reduce costs and accelerate market launch timelines. By managing cross-functional teams, Charles Clark drives the development and implementation of scalable infrastructure. The President and Chief Operating Officer, Precision Medicine Group's focus includes enhancing service delivery and ensuring adherence to quality standards across all projects. This leadership position is pivotal in translating the company's vision into tangible operational successes, directly impacting the speed of regulatory approvals and commercialization efforts. Clark's strategic oversight ensures the company remains at the forefront of supporting life science innovation.
    Charles Clark

    Sofia Baig - President, Precision for Medicine

    Sofia Baig, the President, Precision for Medicine at Precision for Medicine, spearheads the strategic direction and overall business development for the core Precision for Medicine division. Baig guides the expansion of services aimed at supporting life science companies through critical development and commercialization phases. This leadership role involves fostering key partnerships and identifying new market opportunities to enhance the company's impact. By championing innovation, Sofia Baig ensures the platform effectively speeds approval processes and reduces costs for clients. The President, Precision for Medicine's responsibilities include aligning departmental goals with the company's mission to optimize market launch strategies. This executive's vision drives the continuous improvement of the company's infrastructure, ensuring it remains a premier partner for life science organizations seeking to bring novel therapies to market efficiently and effectively.

    Daisy DeWeese-Gatt - President, Clinical Solutions

    Daisy DeWeese-Gatt, the President, Clinical Solutions at Precision for Medicine, directs the comprehensive suite of clinical development services offered by the company. DeWeese-Gatt oversees the strategic planning and execution of clinical trials, ensuring they meet rigorous scientific and regulatory standards. This leadership position is crucial for accelerating the approval process for novel therapies and optimizing their path to market. By managing complex clinical operations, Daisy DeWeese-Gatt ensures efficient resource utilization and cost containment for life science partners. The President, Clinical Solutions' focus includes integrating cutting-edge methodologies and technologies to enhance trial success rates. DeWeese-Gatt's expertise drives the development of robust clinical strategies that support the company's mission to bring life-saving treatments to patients faster and more effectively.
    Daisy DeWeese-Gatt

    James Cheong - Senior VP (Asia Pacific)

    James Cheong, the Senior VP (Asia Pacific) at Precision for Medicine, leads the company's strategic initiatives and operational oversight across the Asia Pacific region. Cheong drives market penetration and business expansion, ensuring the company's services effectively support life science partners in this critical territory. This executive role focuses on adapting global strategies to regional nuances, accelerating approval timelines and optimizing commercialization efforts within diverse markets. By cultivating strong relationships with regional stakeholders, James Cheong enhances the company's presence and impact. The Senior VP (Asia Pacific)'s leadership ensures that the platform's capabilities are leveraged to reduce costs and streamline market entry for clients operating in or targeting the Asia Pacific landscape. Cheong's expertise is vital in navigating complex regulatory environments and driving successful product launches throughout the region.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Precision for Medicine Top Executives and Leadership Team

    Who leads Precision for Medicine?
    Precision for Medicine is led by Eugene Vodovoz (Chief Financial Officer), along with executives such as Charles Clark (President and Chief Operating Officer, Precision Medicine Group) and Sofia Baig (President, Precision for Medicine).
    Who is part of Precision for Medicine’s executive team?
    The executive team of Precision for Medicine includes leaders such as Eugene Vodovoz (Chief Financial Officer), Charles Clark (President and Chief Operating Officer, Precision Medicine Group), Sofia Baig (President, Precision for Medicine) and other senior executives.
    How many executives does Precision for Medicine have?
    Precision for Medicine has 5 executives leading key business areas.
    What roles are included in Precision for Medicine’s leadership team?
    The leadership team of Precision for Medicine includes roles such as Chief Financial Officer, President and Chief Operating Officer, Precision Medicine Group, President, Precision for Medicine, President, Clinical Solutions, Senior VP (Asia Pacific).